Dow Up 1.13% Nasdaq Up 1.41%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
2.96 Down 0.05(1.66%) 4:00PM EDT
Prev Close:3.01
Open:3.08
Bid:3.00 x 500
Ask:3.02 x 3200
1y Target Est:12.50
Beta:1.42
Next Earnings Date: 6-Nov-14SNTA Earnings announcement
Day's Range:2.95 - 3.12
52wk Range:2.62 - 7.22
Volume:787,575
Avg Vol (3m):1,365,070
Market Cap:308.93M
P/E (ttm):N/A
EPS (ttm):-1.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNTA

Comparison

Symbol% ChgMkt Cap
SNTADown 1.66%308.93M
INFIDown 1.38%661.74M
NVSUp 0.80%224.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.02
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback